A Basque mountaineer climbs Kilimanjaro controlling its diabetes thanks to a new telemedicine system
The Basque mountaineer Josu Feijoo has climbed to the top of Kilimanjaro (5,895 meters) controlling his diabetes thanks to a new telemedicine system that has allowed him to make daily measurements of his glucose level at temperatures below 22 degrees and be controlled "inAll times "for your medical team.
"I am the first diabetic patient in the world to transmit my glucose values from the top of Kilimanjaro," said the climber, who with this feat wanted to show that having diabetes is compatible with the dream of conquering the so -called 'Africa roof'.
Through this telemedicine system, marketed by Roche Laboratories, the mountaineer transmitted daily glycemia levels from the different points of the ascension."Being able to perform and transmit values in limit situations is a historical milestone and a technical advance for millions of diabetics who travel around the world or practice sports outside a family environment," he said.
Josu, who lives with type I diabetes for more than 17 years, and his partner Jon Goikoetxea faced the highest peak in Africa after having reached four of its objectives, the McKinley in Alaska (2005);Everest (2006): Elbrus, between Russia and Georgia (2007) and Mount Vinson (2007), the maximum altitude of Antarctica.He has been the world's first diabetic patient to climb Everest and get the North Pole and the South Geographical Pole.
The application used by the patient is composed of a mobile phone-the application that processes glucose information-and glucometer 'ACCU-Chek'.The solution aimed at the doctor who has to respond to these patients is formed by a web application that allows to receive and interpret patient data.
Its operation begins when the person with diabetes is measured glucose with their glucometer and then connects it, through infrared, to their mobile phone, transmitting the information obtained to the doctor.This, in turn, can visualize all the information on a web page that it access safely.
From the point of view of professionals, the main advantage offered by this solution is the security of distance assistance to people with diabetes.Thus, the optional can modify the insulin guidelines of a patient without the need for hospital admission and control their first days at home.For families, this technology represents a saving of time and resources, in addition to avoiding the loss of working hours or study, the company said.
